Association of paraoxonase-1 activity and major depressive disorder in patients with metabolic syndrome

Basit Öğe Kaydı
dc.contributor.authorAri, Hatem
dc.contributor.authorKayrak, Mehmet
dc.contributor.authorGunduz, Mehmet
dc.contributor.authorKayhan, Fatih
dc.contributor.authorKaya, Zeynettin
dc.contributor.authorKiyici, Aysel
dc.contributor.authorUguz, Faruk
dc.date.accessioned2020-03-26T19:01:01Z
dc.date.available2020-03-26T19:01:01Z
dc.date.issued2015
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractAssociations between metabolic syndrome (MS) and major depressive disorder (MDD) are well documented although the underlying biological mechanisms for this relationship are less studied. Paraoxonase (PON1) is a high-density lipoprotein (HDL)-associated enzyme, with demonstrated evidence of strong antioxidant activity. Oxidative stress has been implicated in the pathophysiology of MS and MDD. PON1 activity has been studied to some extent in patients with MS and less in MDD. The aim of this study was to compare serum PON1 activity in patients with MS and MDD, MS without MDD, and normal control groups in the context of the biological mechanism of the association between MS and MDD. In this case-control study, 67 patients with MS and 25 healthy controls from the hospital-university staff were recruited. All patients and healthy controls were assessed by a semi-structured psychiatric interview. Patients with MDD were diagnosed according to the DSM-IV criteria for MDD. Serum PON1 activity was determined with a spectrophotometric method, and the activity was compared between patients with MS and MDD, with MS but without MDD, and control groups. Serum PON1 activity levels were lower in patients with MS and MDD group compared to those in the patients with MS and without MDD group and control group (69.5+/-24.2, 84.3+/-34.6, and 97.1+/-40.8 U/ml, p=0.03, respectively). Post hoc analysis showed that PON1 activity was statically significantly lower in the MS with MDD group than in the control group (p=0.02). Impaired PON1 activity, in the context of enhanced oxidative stress, could be one of the possible underlying biological mechanisms of the MS-MDD association.en_US
dc.identifier.doi10.1007/s13410-015-0385-1en_US
dc.identifier.endpageS263en_US
dc.identifier.issn0973-3930en_US
dc.identifier.issn1998-3832en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpageS258en_US
dc.identifier.urihttps://dx.doi.org/10.1007/s13410-015-0385-1
dc.identifier.urihttps://hdl.handle.net/20.500.12395/31875
dc.identifier.volume35en_US
dc.identifier.wosWOS:000366529000029en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSPRINGER INDIAen_US
dc.relation.ispartofINTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIESen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectMetabolic syndromeen_US
dc.subjectDepressive disorderen_US
dc.subjectParaoxonase-1 activityen_US
dc.titleAssociation of paraoxonase-1 activity and major depressive disorder in patients with metabolic syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu